News|Articles|September 27, 2023
Emmes Introduces Telehealth Capabilities into Advantage eClinical
Scheduled visits can become virtual with video calls augmented directly through the platform and patients signing in through their existing participant portal.
Advertisement
Emmes has announced the addition of telehealth capabilities within Advantage eClinical. The new application means any scheduled visit can become virtual with video calls augmented directly through the platform and patients signing in through their existing participant portal.
The addition of telehealth capabilities is part of a much wider development plan for Emmes' third generation clinical data platform. The platform accommodates all trial modalities—traditional, decentralized including hybrid and fully virtual—as well as the needs of patients, sponsors, and sites. It also includes all tasks from data capturing, cleaning, monitoring, to workflow management, sample tracking and even clinical assessment and engagement tools.
"What we are building with Advantage eClinical is more than an EDC or eCOA/ePRO. It's a platform to accelerate the delivery of all types of trial designs through one unified, modular system. 90% of respondents in the Center for Information and Study on Clinical Research Participation's (CISCRP) 2021 Perception and Insights Study stress the importance of having options for completing study visits, such as virtual and home visits. By eliminating the need for sponsors to procure and set up additional point decentralized trial (DCT) systems, we hope more studies will offer patient-centric options for patients to participate," commented Ching Tian, chief innovation officer at Emmes in a press release.
Ashley Davidson, Emmes associate vice president, product management and operations, explained that the telehealth application makes workflow far simpler for site staff because all information is on screen at the same time, including assessment forms and patient records. In a press release, she commented: "It gives that real world feel of an in-person visit and enables simultaneous note-taking and record-checking. On a more practical level, operating a decentralized or hybrid trial design means we can also open up trials to more diverse groups of participants, which has been a big driver from the regulators."
Reference
Emmes Introduces Telehealth Capabilities into Advantage eClinical. (27 September, 2023). Cision PR Newswire.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Recent Policy Changes Could Impact Clinical Research
September 10th 2025
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial
2
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
3
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
4
eClinical Technology: Misconceptions, Challenges, and Opportunities
5